JEROME RUTOWSKI: Open Payments
NPI 1780996769 · AMHERST, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$526 in 30 payments from 11 companies in 2025. Trend: 2023 $1,019 · 2024 $710 · 2025 $526
Food & beverage: $526
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 15 | $153 |
| Boston Scientific Corporation | 1 | $120 |
| Exact Sciences Corporation | 4 | $67 |
| Abbott Laboratories | 2 | $46 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $43 |
| E.R. Squibb & Sons, L.L.C. | 1 | $17 |
| Daiichi Sankyo Inc. | 1 | $17 |
| Lilly USA, LLC | 1 | $16 |
| PFIZER INC. | 1 | $16 |
| GlaxoSmithKline, LLC. | 1 | $16 |
Products named: WATCHMAN, Wegovy, The Cologuard Plus Collection Kit, FREESTYLE LIBRE 3, ENTYVIO, Ozempic, CAMZYOS, INJECTAFER.
Industry payments across NY — which companies pay providers there.
